Author

Henry B. Rogalin

Observed name: Henry Rogalin

Institution: Seres Therapeutics (United States)

Observed institutions: Tufts University, Seres Therapeutics (United States)

OpenAlex ID: A5009147757

Interplay between the Herpes Simplex Virus 1 gB Cytodomain and the gH Cytotail during Cell-Cell Fusion

2015 · Henry B. Rogalin, Ekaterina E. Heldwein · Journal of Virology · 56

Asymmetric Assembly of Merkel Cell Polyomavirus Large T-Antigen Origin Binding Domains at the Viral Origin

2011 · Celia J. Harrison, Gretchen Meinke, et al. · Journal of Molecular Biology · 48

Calpain-1 knockout reveals broad effects on erythrocyte deformability and physiology

2012 · Adam Wieschhaus, Anwar Khan, et al. · Biochemical Journal · 44

Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1

2016 · Henry B. Rogalin, Ekaterina E. Heldwein · Journal of Virology · 20

1503. Engraftment of Investigational Microbiome Drug, SER-262, in Subjects Receiving Vancomycin Is Associated with Reduced Rates of Recurrence after Primary Clostridium Difficile Infection (CDI)

2019 · Christopher Ford, Kevin Litcofsky, et al. · Open Forum Infectious Diseases · 11

Fusion on a Pedestal: The Structure of the Full-Length HSV-1 Fusogen gB

2017 · Rebecca S. Cooper, Elka R. Georgieva, et al. · Biophysical Journal · 1

Works count: 6

Citation count: 180

H-index: 5

I10-index: 5